Ziņojums Sākt vērot      Pielāgota analīze
Spartan Arb
Demo (GBP), SpartanFX, MetaTrader 4
Track Record Nav Verified
Tirdzniecības privilēģijas nav pārbaudītas.
Apspriest Copy
  • Info
  • Stats
  • General
  • Pieaugums:+239.7%
  • Abs. peļņa: +235.91%
  • Dienas: 0.05%
  • Mēneša: 239.70%
  • Kritums (Drawdown): 1.94%
  • Bilance: £342267.77
  • Kapitāls:(100.00%) £342267.77
  • Augstākais: (Mar 29) £342297.33
  • Peļņa: £240374.31
  • Interese: £62.69
  • Depozīts: £100000.00
  • Izņemts: £0.00
  • Atjaunots:Apr 13 2012 at 22:02
  • Sekošana0
Export
Vairāk
  • Grafiks
  • Izaugsme
  • Bilance
  • Peļņa
  • Kritums (Drawdown)
  • Tirdzniecība
  • Periods
  • Goals
  • Browser
Gain (Difference) Profit (Difference) Pips (Difference) Win % (Difference) Trades (Difference) Lotes (Difference)
Today - - - - - -
This Week - - - - - -
This Month - - - - - -
This Year - - - - - -
  • Paplašināta statistika
  • Darījumi
  • Apkopojums
  • Stundas
  • Dienas
  • Riska Ruin
  • Ilgums
  • MAE/MFE
Darījumi: 2090
Rentabilitāte:
Pipi: 3231.7
Vidējā peļņa: 3.33 pips / £284.74
Vidēji zaudēts: -2.03 pips / -£225.66
Lotes: 28,706
Komisijas: -£8140.00
Sekmīga pirkšana: (1148/1780) 64%
Sekmīga pārdošana: (247/310) 79%
Labākais darījums(£): (Mar 23) 3936.31
Sliktākais darījums(£): (Mar 26) -474.56
Labākais darījums(pipi): (Mar 22) 33.0
Sliktākais darījums(punkti): (Mar 20) -5.9
Vid. darījuma ilgums: 6m
Peļņas faktors: 2.53
Standarta novirze: £393.34
Sharpe Ratio: 0.32
Z-Score (Iespējamība): -1.89 (96.40%)
Gaidāms: 1.5 Pipi / £115.01
AHPR: 0.06%
GHPR: 0.06%

Filtrs
  • Tirdzniecības aktivitāte
  • Atvērtie darījumi (0)
  • Atvērtie darījumi (0)
  • Vēsture (2095)
  • Exposure
Nav datu attēlošanai.

Vairāk
  • Mēneša analīze
  • 2012
Other Systems by virtualvk
Vārds Pieaugums Kritums (Drawdown) Pipi Tirdzniecība Kredīta plecs Tips
PLIM -99.90% 99.91% -1520.5 - 1:500 Reāls
Aleks Bozhko2 104.58% 47.30% 712.6 - - Demo
GPES792466 -15.97% 16.04% -787.5 - - Demo
ASTO792553 0.88% 0.18% 213.7 - - Demo
JLOP792676 2.24% 2.29% 391.9 - - Demo
WDDA792469 5.60% 7.91% 434.0 - - Demo
VEFO792906 1.56% 0.14% 57.2 - - Demo
AFOREX102559 -98.55% 98.98% -8.6 - 1:200 Reāls
MFER 792301 210.96% 31.22% 1400.0 - - Demo
MFER 793297 22.18% 48.08% 1539.9 - - Demo
Adv Mkts Arb. 2081137 17.46% 3.21% 535.5 - 1:100 Demo
Night Scalper AM -1.89% 2.25% 3.0 - 1:100 Demo
VEFO 792904 1.89% 0.15% 35.3 - - Demo
Impulse Scalp 26.36% 5.12% 411.8 - - Demo
9000059 AM -90.25% 90.25% -633.7 - 1:100 Demo
801708 PFG 0.23% 2.72% 2.3 - - Demo
801875 PFG 0.99% 2.24% 8.3 - - Demo
801879 PFG -0.28% 0.97% -2.8 - - Demo
801882 PFG -1.17% 1.65% -11.7 - - Demo
802343 PFG -0.58% 0.00% -5.4 - - Demo
801990 PFG -1.30% 1.93% -10.4 - - Demo
802384 PFG -0.36% 0.02% -27.5 - - Demo
802385 PFG -0.37% 0.01% -26.1 - - Demo
802386 PFG -0.26% 0.03% -14.1 - - Demo
802387 PFG -0.52% 0.03% -31.4 - - Demo
802388 PFG -0.20% 0.19% -1.6 - - Demo
802389 PFG -0.76% 0.03% -45.0 - - Demo
MSUKREAL92467 242.44% 27.46% 16910.0 - 1:500 Reāls
Mt4-9000191 -16.41% 35.71% 86.0 - - Reāls
VLISTeleTrade -87.51% 98.48% 5579.0 - - Demo
Trade Balance (1h 0min)
GBP/USD Technical Analysis: Cable constr...(2 min ago)
EURUSD 1.13006 GBPUSD 1.25809
USDJPY 113.401 USDCAD 1.3394

Tools

Kopiena

Apskats

Brokeri

Platforma

Atbalsts


Twitter |  Facebook |  Lapas karte  |  Noteikumi  |   Privacy Policy
©2018 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment; do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.